Cargando…
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease
BACKGROUND AND OBJECTIVES: The safety of inflammatory bowel disease medications during lactation is of significant relevance to women of childbearing potential. Available data regarding the transfer of biologic agents for inflammatory bowel disease via breast milk are limited to case reports. The ob...
Autores principales: | Sun, Wan, Fennimore, Blair, Beaulieu, Dawn B., Arsenescu, Razvan, Stein, Adam C., Chen, Jingjing, Lin, Tiffany, McKnight, Sonya, Kadali, Harisha, Rosario, Maria, Lirio, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195772/ https://www.ncbi.nlm.nih.gov/pubmed/33544318 http://dx.doi.org/10.1007/s40262-021-00985-4 |
Ejemplares similares
-
Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases
por: Sun, Wan, et al.
Publicado: (2020) -
Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study
por: Hyams, Jeffrey S, et al.
Publicado: (2022) -
Human Milk and Lactation
por: Gianni, Maria Lorella, et al.
Publicado: (2020) -
Vedolizumab Immunogenicity With Long‐Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease
por: Wyant, Timothy, et al.
Publicado: (2021) -
Carcinogens in Rat Milk: Transfer of Ingested Diethylnitrosamine into Milk by Lactating Rats
por: Schoental, R., et al.
Publicado: (1974)